November 24, 2021

Ocuphire Pharma, Inc. (OCUP) stock surged 59.20% in the pre-market trading session at the price of $5.54 after it published the enrollment of the first patients in MIRA-3 Phase-III pivotal trial for Nyxol. Ocuphire is a clinical-stage ophthalmic biopharmaceutical firm that develops and commercializes therapeutics to treat eye disorders. Enrollment of Patients in MIRA-3 Pivotal Trial […]

Shares of the PTN stock were rising in the premarket trading session today on November 24, 2021. PTN stock price saw a push of 53.74% to reach $0.53 a share at the time of this writing. The stock was gloomy in the previous trade and went down by 2.71% at closing. Let’s dig in to

Golden Ocean Group Limited (GOGL) stock surged 9.39% in the pre-market trading session at the price of $8.74 after it announced an earnings report for the third quarter that ended on 30th September 2021.   GOGL Third Quarter 2021 Financial Results On 24th November 2021, GOGL announced its financial results for the third quarter ended on

Gracell Biotechnologies Inc. (GRCL) experienced a decline of 4.88% in the premarket following the announcement of the Senior Management Team Share Purchase Plan. However, the last trading session concluded at $7.79 with an incline of 22.1%. Senior Management Team Shares Purchase Plan – What’s up? On 23rd November 2021, GRCL announced that Dr. William (Wei)

Inspira Technologies Oxy B.H.N. Ltd. (IINN) stock surged 39.16% in the pre-market trading session at the price of $3.98 after it published financial results for the third quarter ended on 30th September 2021. Inspira Technologies is an advanced medical technology firm that provides respiratory treatments. It has designed an Augmented Respiration Technology (ART) to rebalance

SeqLL Inc. (SQL) saw a push of 10.89% in the premarket. However, the last trading session closed at $2.48 with an increase of 1.22%. Coronary Artery Disease Detection & SQL On 27th September 2021, it was announced that in the September edition of BMC Medical Genomics, SQL’s tSMS platform was used to publish a peer-reviewed

Outlook Therapeutics, Inc. (OTLK) stock plunged 21.15% in the pre-market trading session at the price of $1.23 following the announcement of a $50 million bought deal offering of common stock. Outlook Therapeutics is a leading biopharmaceutical firm. It has developed and launched ONS-5010/ LYTENAVA as the first FDA-approved ophthalmic formulation of bevacizumab to treat retinal

Q&K International Group Limited (QK) saw a push of 8.05% in the premarket. However, the last trading session concluded at $0.5553 with an incline of 0.96%. Disposal of WFOE QK announced the disposal of WFOE on 26th October 2021. The Disposal was carried out in order to redirect the Company’s business resources to its subsidiaries

Pure Storage Inc. (PSTG) gained a good 14.88% pre-market, at $31.34 on November 24. The stock lost 0.73% in the previous trading session, to close at $27.28 at a volume of 3.73 million. During the active market session, the stock went as high as $27.76 and as low as $26.82. While in the 52-week range